Carbylan Biosurgery, Inc
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2015 | $4 M | No. 3 | $2 to $10 million | debt, options | SEC | |
| Sep 2014 | $5 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| Dec 2012 | $6 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Carbylan Biosurgery, Inc chose not to state its revenue in its newest notice of a funding round (Mar 2015).
SEC Form D · Mar 2015
The industry group it chose in its notices: Other Health Care.
SEC Form D · Mar 2015
That is all the official record says: Carbylan Biosurgery, Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
7 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Acmp IV LLC | Other | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Acp IV, L.P. | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| InterWest Management Partners IX, LLC | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| InterWest Partners IX, LP | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Vivo Ventures Fund VI, L.P. | Venture capital | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Vivo Ventures VI Affiilates Fund, L.P. | Venture capital | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Vivo Ventures VI, LLC | Venture capital | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 4 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David M. Gravett | Executive officer | Mar 2015 |
| David M. Renzi | Executive officer | Mar 2015 |
| Hayley M. Lewis | Executive officer | Mar 2015 |
| Marcee M. Maroney | Executive officer | Mar 2015 |
| T. Michael White | Executive officer | Mar 2015 |
| Timothy L. Trapp | Executive officer | Oct 2014 |
| David Gravett | Executive officer | Jan 2013 |
| George Daniloff | Executive officer | Jan 2013 |
| Marcee Maroney | Executive officer | Jan 2013 |
| Mark Weeks | Executive officer | Jan 2013 |
| Roxanne Dubois | Executive officer | Jan 2013 |
| Albert L. Cha | Director | Mar 2015 |
| David M. Renzi | Director | Mar 2015 |
| David W. Clapper | Director | Mar 2015 |
| Edward W. Unkart | Director | Mar 2015 |
| Guy P. Nohra | Director | Mar 2015 |
| Keith A. Katkin | Director | Mar 2015 |
| Reza P. Zadno | Director | Mar 2015 |
| Steven L. Basta | Director | Mar 2015 |
| Albert Cha | Director | Jan 2013 |
| Chris Ehrlich | Director | Jan 2013 |
| George Daniloff | Director | Jan 2013 |
| Guy Nohra | Director | Jan 2013 |
| Steven Basta | Director | Jan 2013 |